SCHEMBL1940232

SCHEMBL1940232

CN(C)c1cc[n+](C)cc1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.61
LMNA P02545 3/20 0.61
HTT P42858 3/20 0.61
SMN1; SMN2 Q16637 3/20 0.61
MEN1 O00255 1/20 0.61
MAPT P10636 1/20 0.61
ALPG P10696 1/20 0.61
THRB P10828 1/20 0.61
GFER P55789 1/20 0.61
KMT2A Q03164 1/20 0.61
NPSR1 Q6W5P4 1/20 0.61
TSHR P16473 2/20 0.56
ALOX15 P16050 2/20 0.56
HSD17B10 Q99714 1/20 0.56
CHKA P35790 7/20 0.50
HDAC8 Q9BY41 3/20 0.46
TP53 P04637 1/20 0.43
CYP3A4 P08684 1/20 0.43
MAPK1 P28482 1/20 0.43
TDP1 Q9NUW8 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL3748847 0.97 ALDH1A1 (0.59) ALDH1A1LMNAHTTSMN1; SMN2MEN1
Iodide SCHEMBL3748614 0.97 ALDH1A1 (0.65) ALDH1A1LMNAHTTSMN1; SMN2MEN1
SCHEMBL12315045 0.85 ALDH1A1 (0.59) ALDH1A1LMNAHTTSMN1; SMN2MEN1
Iodide SCHEMBL1885085 0.83 ALDH1A1 (0.62) ALDH1A1LMNAHTTSMN1; SMN2MEN1
SCHEMBL1898081 0.79 MEN1 (0.96) ALDH1A1LMNAHTTSMN1; SMN2MEN1
SCHEMBL1898080 0.79 MEN1 (0.96) ALDH1A1LMNAHTTSMN1; SMN2MEN1
SCHEMBL25664229 0.79 ALDH1A1 (0.61) ALDH1A1LMNAHTTSMN1; SMN2MEN1
SCHEMBL13614031 0.79 MAPT (0.53) ALDH1A1LMNAHTTSMN1; SMN2MEN1
SCHEMBL7050647 0.79 ALDH1A1 (0.61) ALDH1A1LMNAHTTSMN1; SMN2MEN1
SCHEMBL15875307 0.78 ALDH1A1 (0.43) ALDH1A1LMNAHTTSMN1; SMN2MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 155 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2195330-B1 Method and agent for refolding proteins MERCK PATENT GMBH (DE) 2013-03-13 EP claimed
US-20100292447-A1 METHOD AND AGENT FOR REFOLDING PROTEINS MERCK PATENT GESELLSCHAFT (DE) 2010-11-18 US claimed
EP-0398358-B1 Aluminum electroplating method MITSUBISHI PETROCHEMICAL CO (JP) 1994-03-09 EP claimed
EP-4703355-A1 FLUORINE-CONTAINING ISOXAZOLONE COMPOUND AND PRODUCTION METHOD FOR SAME Unimatec Co., Ltd. (JP) 2026-03-04 EP disclosed
EP-4663629-A1 FLUORINATED PYRAZOLONE COMPOUND AND METHOD FOR PRODUCING SAME Unimatec Co., Ltd. (JP) 2025-12-17 EP disclosed
EP-4631934-A1 FLUORINE-CONTAINING ISOXAZOLE COMPOUND AND METHOD FOR PRODUCING SAME Unimatec Co., Ltd. (JP) 2025-10-15 EP disclosed
WO-2024225214-A1 FLUORINE-CONTAINING ISOXAZOLONE COMPOUND AND PRODUCTION METHOD FOR SAME ユニマテック株式会社 2024-10-31 WO disclosed
WO-2024166973-A1 FLUORINATED PYRAZOLONE COMPOUND AND METHOD FOR PRODUCING SAME ユニマテック株式会社 2024-08-15 WO disclosed
WO-2024122444-A1 FLUORINE-CONTAINING ISOXAZOLE COMPOUND AND METHOD FOR PRODUCING SAME ユニマテック株式会社 2024-06-13 WO disclosed
US-20240069257-A1 CHOLESTERIC LIQUID CRYSTAL LAYER, METHOD OF FORMING CHOLESTERIC LIQUID CRYSTAL LAYER, LAMINATE, LIGHT GUIDE ELEMENT, AND IMAGE DISPLAY DEVICE FUJIFILM CORPORATION (JP) 2024-02-29 US disclosed
US-11828960-B2 Cholesteric liquid crystal layer, method of forming cholesteric liquid crystal layer, laminate, light guide element, and image display device FUJIFILM CORPORATION (JP) 2023-11-28 US disclosed
US-20070148458-A1 ENCAPSULATED CHROMONIC PARTICLES 3M INNOVATIVE PROPERTIES COMPANY 2007-06-28 US disclosed
US-20070140957-A1 HIERARCHICAL CHROMONIC STRUCTURES 3M INNOVATIVE PROPERTIES COMPANY 2007-06-21 US disclosed
US-20070141351-A1 MULTILAYERED CHROMONIC STRUCTURES 3M INNOVATIVE PROPERTIES COMPANY 2007-06-21 US disclosed
US-20070134301-A1 Silver Ion Releasing Articles and Methods of Manufacture 3M INNOVATIVE PROPERTIES COMPANY 2007-06-14 US disclosed
US-20070128291-A1 Method and Apparatus for Forming Chromonic Nanoparticles 3M INNOVATIVE PROPERTIES COMPANY 2007-06-07 US disclosed
WO-2007064029-A1 OPTICAL COMPENSATION FILM, POLARIZING PLATE AND LIQUID CRYSTAL DISPLAY DEVICE FUJIFILM CORPORATION (JP) 2007-06-07 WO disclosed
US-20070086964-A1 Method for making chromonic nanoparticles 3M INNOVATIVE PROPERTIES COMPANY 2007-04-19 US disclosed
US-20070086965-A1 Chromonic nanoparticles containing bioactive compounds 3M INNOVATIVE PROPERTIES COMPANY 2007-04-19 US disclosed
US-20060116464-A1 Nanocomposites comprising telechelic polyesters and organoclays GENERAL ELECTRIC COMPANY 2006-06-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100292447-A1 METHOD AND AGENT FOR REFOLDING PROTEINS HSPA5, MRPL21, HSPBP1 ALDH1A1 3592/4885LMNA 2502/4885HTT 505/4885
US-20070128291-A1 Method and Apparatus for Forming Chromonic Nanoparticles CHMP4B, ANXA6, ATXN10 ALDH1A1 3591/4885LMNA 250/4885HTT 51/4885
US-20070141351-A1 MULTILAYERED CHROMONIC STRUCTURES RCC1, PICALM, CDYL ALDH1A1 3550/4885LMNA 574/4885HTT 583/4885
US-20070140957-A1 HIERARCHICAL CHROMONIC STRUCTURES RCC1, PICALM, SMC1A ALDH1A1 3658/4885LMNA 777/4885HTT 374/4885
US-20070086965-A1 Chromonic nanoparticles containing bioactive compounds RCC1, CTRL, CASP12 ALDH1A1 4084/4885LMNA 271/4885HTT 845/4885
US-20070134301-A1 Silver Ion Releasing Articles and Methods of Manufacture SLC18A1, CD68, ORAI1 ALDH1A1 2198/4885LMNA 3496/4885HTT 1272/4885
US-20070086964-A1 Method for making chromonic nanoparticles CA13, CHRNA6, CA12 ALDH1A1 3727/4885LMNA 209/4885HTT 802/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.